August 04, 2023
Immunoglobulin Free Light Chains in Severe Asthma Patient: could they be a new biomar...
Cristiano Caruso, Gabriele Ciasca, * Baglivo, et al.
October 24, 2023
EUFOREA/EPOS2020 Statement on the Clinical Considerations for CRSwNP Care
Wytske Fokkens, Peter Hellings, Isam Alobid, et al.
October 13, 2022
Comparative effectiveness of Anti-IL5 and Anti-IgE biologic classes in severe asthma...
David Price, paul pfeffer, Nasloon Ali, et al.
April 25, 2022
Biologics and Airway Remodeling in Severe Asthma
Gilda Varricchi, Sebastian Ferri, Jack Pepys, et al.
January 15, 2021
Allergen immunotherapy: the growing role of observational and randomised trial “real-...
Giovanni Paoletti, Danilo Di Bona, Derek Chu, et al.
September 24, 2020
Development and validation of Nasal Polyposis Quality of Life Questionnaire (NPQ)
Ilaria Baiardini, Giovanni Paoletti, Alessia Mariani, et al.
June 28, 2020
COVID-19 in Severe Asthma Network in Italy (SANI) patients: clinical features, impact...
Enrico Heffler, Caterina Detoraki, Marco Contoli, et al.
June 26, 2020
Care about patients with chronic rhinosinusitis and type-2 inflammation       
Francesca Pirola, Enrico Heffler, Giovanni Paoletti, et al.
June 24, 2020
COVID-19 in Severe Asthma Network in Italy (SANI) patients: clinical features, impact...
Enrico Heffler, Caterina Detoraki, Marco Contoli, et al.